The discovery of the antiviral resistance gene Mx: A story of great ideas, great failures, and some success

Annual Review of Virology

Volumn 5, Issue , 2018, Pages 33-51

  Haller, Otto ^a,b   Arnheiter, Heinz ^c   Pavlovic, Jovan ^d   Staeheli, Peter ^a,b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^d UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

dynamin like large GTPase; HIV; influenza virus; interferon; Mx; Mx transgenic animals; myxovirus resistance gene

Indexed keywords

COMPLEMENTARY DNA; INTERFERON; MYXOVIRUS RESISTANCE PROTEIN; VIRUS DNA;

ANTIVIRAL RESISTANCE; ARTICLE; BONE MARROW; CHIMERA; CLONING; GENE IDENTIFICATION; GENETIC SUSCEPTIBILITY; HUMAN; INFECTION SENSITIVITY; INFLUENZA VIRUS; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC ANIMAL; VIROLOGY; VIRUS GENE; VIRUS REPLICATION; ANIMAL; DISEASE RESISTANCE; HISTORY; IMMUNOLOGY; INNATE IMMUNITY; MEDICAL RESEARCH; METABOLISM; VIRUS;

ANIMALS; BIOMEDICAL RESEARCH; DISEASE RESISTANCE; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; IMMUNITY, INNATE; INTERFERONS; MYXOVIRUS RESISTANCE PROTEINS; VIRUSES;

EID: 85054242574     PISSN: 2327056X     EISSN: 23270578     Source Type: Journal    
DOI: 10.1146/annurev-virology-092917-043525     Document Type: Article

References (140)

1. MacKenzie D. 1993. Inventing Accuracy: A Historical Sociology of Nuclear Missile Guidance. Cambridge, MA: MIT Press
2. Lindenmann J. 1964. Inheritance of resistance to influenza virus in mice. Proc. Soc. Exp. Biol. Med. 116:506-9
3. Isaacs A, Lindenmann J. 1957. Virus interference. I. The interferon. Proc. R. Soc. B 147:258-67
4. Haller O. 2015. A tribute to Jean Lindenmann, co-discoverer of interferon (1924-2015). Cytokine 76: 113-15
5. Lindenmann J. 2005. Of mice and man\-The Mx connection. In Comprehensive Biochemistry, Vol. 44: Selected Topics in the History of Biochemistry: Personal Recollections IX, ed. G Semenza, AJ Turner, pp. 267-95. Amsterdam: Elsevier
6. Ungar J, Basil B. 1957. Routine experience of the mouse-protection assay of pertussis vaccine. J. Hyg. 55:45-49
7. Lindenmann J. 1962. Resistance of mice to mouse-adapted influenza A virus. Virology 16:203-4
8. Sawyer WA, Lloyd W. 1931. The use of mice in tests of immunity against yellow fever. J. Exp. Med. 54:533-55
9. Webster LT. 1937. Inheritance of resistance ofmice to enteric bacterial and neurotropic virus infections. J. Exp. Med. 65:261-86
10. Sabin AB. 1952. Nature of inherited resistance to viruses affecting the nervous system. PNAS 38:540-46
11. Vainio T, Gwatkin R, Koprowski H. 1961. Production of interferon by brains of genetically resistant and susceptible mice infected with West Nile virus. Virology 14:385-87
12. Bang FB, Warwick A. 1960. Mouse macrophages as host cells for the mouse hepatitis virus and the genetic basis of their susceptibility. PNAS 46:1065-75
13. Lindenmann J, Klein P. 1966. Further studies on the resistance of mice to myxoviruses. Arch. Gesamte Virusforsch. 19:1-12
14. Lindenmann J, Lane CA, Hobson D. 1963. The resistance of A2G mice to myxoviruses. J. Immunol. 90:942-51
15. Rusanova NA, Solov'ev VD. 1966. [On the problem of natural antiviral immunity. The hereditary character and mechanism of resistance of mice of the A2G line to influenza virus]. Vopr. Virusol. 11:398-402 (In Russian)
16. Lindenmann J. 1963. Viral oncolysis with host survival. Proc. Soc. Exp. Biol. Med. 113:85-91
17. Lindenmann J, Klein P. 1967. Immunological Aspects of Viral Oncolysis.Heidelberg, Ger.: Springer-Verlag
18. Cattaneo R, Russell SJ. 2017. How to develop viruses into anticancer weapons. PLOS Pathog. 13:e1006190
19. Fiske RA, Klein PA. 1975. Effect of immunosuppression on the genetic resistance of A2G mice to neurovirulent influenza virus. Infect. Immun. 11:576-87
20. Mayer V, Schulman JL, Kilbourne ED. 1973. Nonlinkage of neurovirulence exclusively to viral hemagglutinin or neuraminidase in genetic recombinants of A-NWS (H0N1) influenza virus. J. Virol. 11:272-78
21. Haller O. 1975. A mouse hepatotropic variant of influenza virus. Arch. Virol. 49:99-116
22. Haller O, Arnheiter H, Lindenmann J. 1976. Genetically determined resistance to infection by hepatotropic influenza A virus in mice: effect of immunosuppression. Infect. Immun. 13:844-54
23. Arnheiter H, Haller O, Lindenmann J. 1976. Pathology of influenza hepatitis in susceptible and genetically resistant mice. Exp. Cell Biol. 44:95-107
24. Haller O, Lindenmann J. 1974. Athymic (nude) mice express gene for myxovirus resistance. Nature 250:679-80
25. Goodman GT, KoprowskiH. 1962. Macrophages as a cellular expression of inherited natural resistance. PNAS 48:160-65
26. Lindenmann J, Deuel E, Fanconi S, Haller O. 1978. Inborn resistance of mice to myxoviruses: macrophages express phenotype in vitro. J. Exp. Med. 147:531-40
27. Godleski JJ, Brain JD. 1972. The origin of alveolar macrophages in mouse radiation chimeras. J. Exp. Med. 136:630-43
28. Howard J. 1978. The origin and immunological significance of Kupffer cells. In Mononuclear Phagocytes, ed. R van Furth, pp. 178-99. Oxford, UK: Blackwell Sci.
29. Haller O, Hansson M, Kiessling R, Wigzell H. 1977. Role of non-conventional natural killer cells in resistance against syngeneic tumour cells in vivo. Nature 270:609-11
30. Baldwin R. 1977. Immune surveillance revisited. Nature 270:557
31. HallerO, Arnheiter H, Lindenmann J. 1979. Natural, genetically determined resistance toward influenza virus in hemopoietic mouse chimeras. Role of mononuclear phagocytes. J. Exp. Med. 150:117-26
32. Virelizier JL, Gresser I. 1978. Role of interferon in the pathogenesis of viral diseases of mice as demonstrated by the use of anti-interferon serum. V. Protective role in mouse hepatitis virus type 3 infection of susceptible and resistant strains of mice. J. Immunol. 120:1616-19
33. Gresser I,Tovey MG,Maury C, BanduMT. 1976. Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. II. Studies with herpes simplex, Moloney sarcoma, vesicular stomatitis, Newcastle disease, and influenza viruses. J. Exp. Med. 144:1316-23
34. Haller O, Arnheiter H, Gresser I, Lindenmann J. 1979. Genetically determined, interferon-dependent resistance to influenza virus in mice. J. Exp. Med. 149:601-12
35. De Maeyer-Guignard J, Tovey MG, Gresser I, DeMaeyer E. 1978. Purification of mouse interferon by sequential affinity chromatography on poly(U)-and antibody-agarose columns. Nature 271:622-25
36. Haller O, Arnheiter H, Lindenmann J, Gresser I. 1980. Host gene influences sensitivity to interferon action selectively for influenza virus. Nature 283:660-62
37. Schoggins JW, Rice CM. 2011. Interferon-stimulated genes and their antiviral effector functions. Curr. Opin. Virol. 1:519-25
38. Arnheiter H. 1980. Primary monolayer culture of adult mouse hepatocytes-A model for the study of hepatotropic viruses. Arch. Virol. 63:11-22
39. Arnheiter H, Baechi T, Haller O. 1982. Adult mouse hepatocytes in primary monolayer culture express genetic resistance to mouse hepatitis virus type 3. J. Immunol. 129:1275-81
40. Arnheiter H, Haller O, Lindenmann J. 1980. Host gene influence on interferon action in adult mouse hepatocytes: specificity for influenza virus. Virology 103:11-20
41. Arnheiter H, Staeheli P. 1983. Expression of interferon dependent resistance to influenza virus in mouse embryo cells. Arch. Virol. 76:127-37
42. Haller O, Arnheiter H, Gresser I, Lindenmann J. 1981. Virus-specific interferon action. Protection of newborn Mx carriers against lethal infection with influenza virus. J. Exp. Med. 154:199-203
43. Haller O. 1981. Inborn resistance of mice to orthomyxoviruses. Curr. Top. Microbiol. Immunol. 92:25-52
44. Arnheiter H, Haller O. 1983. Mx gene control of interferon action: different kinetics of the antiviral state against influenza virus and vesicular stomatitis virus. J. Virol. 47:626-30
45. Lengyel P. 1982. Biochemistry of interferons and their actions. Annu. Rev. Biochem. 51:251-82
46. Staeheli P, Horisberger MA, Haller O. 1984. Mx-dependent resistance to influenza viruses is induced by mouse interferons αand βbut not γ. Virology 132:456-61
47. Simon A, Fah J, Haller O, Staeheli P. 1991. Interferon-regulated Mx genes are not responsive to interleukin-1, tumor necrosis factor, and other cytokines. J. Virol. 65:968-71
48. Holzinger D, Jorns C, Stertz S, Boisson-Dupuis S, Thimme R, et al. 2007. Induction of MxA gene expression by influenza A virus requires type I or type III interferon signaling. J. Virol. 81:7776-85
49. MordsteinM,NeugebauerE,DittV, JessenB,RiegerT, et al. 2010. Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections. J. Virol. 84:5670-77
50. Horisberger MA, Haller O, Arnheiter H. 1980. Interferon-dependent genetic resistance to influenza virus in mice: Virus replication in macrophages is inhibited at an early step. J. Gen. Virol. 50:205-10
51. Plotch SJ, Bouloy M, Ulmanen I, Krug RM. 1981. A unique cap(m7GpppXm)-dependent influenza virion endonuclease cleaves capped RNAs to generate the primers that initiate viral RNA transcription. Cell 23:847-58
52. Krug RM, Shaw M, Broni B, Shapiro G, Haller O. 1985. Inhibition of influenza viral mRNA synthesis in cells expressing the interferon-induced Mx gene product. J. Virol. 56:201-6
53. Broni B, Julkunen I, Condra JH, Davies ME, Berry MJ, Krug RM. 1990. Parental influenza virion nucleocapsids are efficiently transported into the nuclei ofmurine cells expressing the nuclear interferoninduced Mx protein. J. Virol. 64:6335-40
54. Pavlovic J, Haller O, Staeheli P. 1992. Human and mouse Mx proteins inhibit different steps of the influenza virus multiplication cycle. J. Virol. 66:2564-69
55. Stranden AM, Staeheli P, Pavlovic J. 1993. Function of the mouse Mx1 protein is inhibited by overexpression of the PB2 protein of influenza virus. Virology 197:642-51
56. Verhelst J, Van Hoecke L, Spitaels J, De Vlieger D, Kolpe A, Saelens X. 2017. Chemical-controlled activation of antiviral myxovirus resistance protein 1. J. Biol. Chem. 292:2226-36
57. Huang T, Pavlovic J, Staeheli P, Krystal M. 1992. Overexpression of the influenza virus polymerase can titrate out inhibition by the murine Mx1 protein. J. Virol. 66:4154-60
58. Samuel CE, Joklik WK. 1974. A protein synthesizing system from interferon-treated cells that discriminates between cellular and viral messenger RNAs. Virology 58:476-91
59. Clemens MJ,Williams BR. 1978. Inhibition of cell-free protein synthesis by pppA2p5A2p5 A: a novel oligonucleotide synthesized by interferon-treated L cell extracts. Cell 13:565-72
60. Hovanessian AG, Kerr IM. 1979. The (2-5) oligoadenylate (ppA2-5A2-5A) synthetase and protein kinase(s) from interferon-treated cells. Eur. J. Biochem. 93:515-26
61. Baglioni C. 1979. Interferon-induced enzymatic activities and their role in the antiviral state. Cell 17:255-64
62. O'Farrell PZ, Goodman HM, O'Farrell PH. 1977. High resolution two-dimensional electrophoresis of basic as well as acidic proteins. Cell 12:1133-41
63. Horisberger MA. 1980. The large P proteins of influenza A viruses are composed of one acidic and two basic polypeptides. Virology 107:302-5
64. HorisbergerMA, Staeheli P, Haller O. 1983. Interferon induces a unique protein in mouse cells bearing a gene for resistance to influenza virus. PNAS 80:1910-14
65. Staeheli P, Dreiding P, Haller O, Lindenmann J. 1985. Polyclonal and monoclonal antibodies to the interferon-inducible protein Mx of influenza virus-resistant mice. J. Biol. Chem. 260:1821-25
66. Dreiding P, Staeheli P, Haller O. 1985. Interferon-induced protein Mx accumulates in nuclei of mouse cells expressing resistance to influenza viruses. Virology 140:192-96
67. Engelhardt OG, Sirma H, Pandolfi PP, Haller O. 2004. Mx1 GTPase accumulates in distinct nuclear domains and inhibits influenza A virus in cells that lack promyelocytic leukaemia protein nuclear bodies. J. Gen. Virol. 85:2315-26
68. Engelhardt OG, Ullrich E, Kochs G, Haller O. 2001. Interferon-induced antiviral Mx1 GTPase is associated with components of the SUMO-1 system and promyelocytic leukemia protein nuclear bodies. Exp. Cell Res. 271:286-95
69. Arnheiter H, Haller O. 1988. Antiviral state against influenza virus neutralized by microinjection of antibodies to interferon-induced Mx proteins. EMBO J. 7:1315-20
70. Staeheli P, HallerO. 1985. Interferon-induced human protein with homology to proteinMx of influenza virus-resistant mice. Mol. Cell. Biol. 5:2150-53
71. Nagata S, Taira H, Hall A, Johnsrud L, Streuli M, et al. 1980. Synthesis in E. coli of a polypeptide with human leukocyte interferon activity. Nature 284:316-20
72. Staeheli P, Haller O, BollW, Lindenmann J,Weissmann C. 1986. Mx protein: constitutive expression in 3T3 cells transformed with cloned Mx cDNA confers selective resistance to influenza virus. Cell 44:147-58
73. Rothman JH, Raymond CK, Gilbert T, O'Hara PJ, Stevens TH. 1990. A putative GTP binding protein homologous to interferon-inducible Mx proteins performs an essential function in yeast protein sorting. Cell 61:1063-74
74. Obar RA, Collins CA, Hammarback JA, Shpetner HS, Vallee RB. 1990. Molecular cloning of the microtubule-associated mechanochemical enzyme dynamin reveals homology with a new family of GTPbinding proteins. Nature 347:256-61
75. Haller O, Staeheli P, Schwemmle M, Kochs G. 2015. Mx GTPases: dynamin-like antiviral machines of innate immunity. Trends Microbiol. 23:154-63
76. Mitchell PS, Patzina C, Emerman M, Haller O, Malik HS, Kochs G. 2012. Evolution-guided identification of antiviral specificity determinants in the broadly acting interferon-induced innate immunity factor MxA. Cell Host Microbe 12:598-604
77. Mitchell PS, Emerman M, Malik HS. 2013. An evolutionary perspective on the broad antiviral specificity of MxA. Curr. Opin. Microbiol. 16:493-99
78. Staeheli P, Grob R, Meier E, Sutcliffe JG, Haller O. 1988. Influenza virus-susceptible mice carry Mx genes with a large deletion or a nonsense mutation. Mol. Cell. Biol. 8:4518-23
79. Haller O, Acklin M, Staeheli P. 1987. Influenza virus resistance of wild mice:Wild-type and mutant Mx alleles occur at comparable frequencies. J. Interferon Res. 7:647-56
80. Jin HK, Yamashita T, Ochiai K, Haller O, Watanabe T. 1998. Characterization and expression of the Mx1 gene in wild mouse species. Biochem. Genet. 36:311-22
81. Guenet JL, Bonhomme F. 2003. Wild mice: an ever-increasing contribution to a popular mammalian model. Trends Genet. 19:24-31
82. Iwasaki A. 2016. Antiviral responses of inbred mice. Nat. Rev. Immunol. 16:339
83. Pillai PS, Molony RD, Martinod K, Dong H, Pang IK, et al. 2016. Mx1 reveals innate pathways to antiviral resistance and lethal influenza disease. Science 352:463-66
84. Haller O, Frese M, Rost D, Nuttall PA, Kochs G. 1995. Tick-borne Thogoto virus infection in mice is inhibited by the orthomyxovirus resistance gene product Mx1. J. Virol. 69:2596-601
85. Staeheli P, Sutcliffe JG. 1988. Identification of a second interferon-regulated murine Mx gene. Mol. Cell. Biol. 8:4524-28
86. Staeheli P, Pravtcheva D, Lundin LG, Acklin M, Ruddle F, et al. 1986. Interferon-regulated influenza virus resistance gene Mx is localized on mouse chromosome 16. J. Virol. 58:967-69
87. Reeves RH, O'Hara BF, Pavan WJ, Gearhart JD, Haller O. 1988. Genetic mapping of the Mx influenza virus resistance gene within the region of mouse chromosome 16 that is homologous to human chromosome 21. J. Virol. 62:4372-75
88. Zurcher T, Pavlovic J, Staeheli P. 1992. Mouse Mx2 protein inhibits vesicular stomatitis virus but not influenza virus. Virology 187:796-800
89. Zurcher T, Pavlovic J, Staeheli P. 1992. Nuclear localization of mouse Mx1 protein is necessary for inhibition of influenza virus. J. Virol. 66:5059-66
90. Johannes L, Arnheiter H, Meier E. 1993. Switch in antiviral specificity of a GTPase upon translocation from the cytoplasm to the nucleus. J. Virol. 67:1653-57
91. Staeheli P, Yu YX, Grob R, Haller O. 1989. A double-stranded RNA-inducible fish gene homologous to the murine influenza virus resistance gene Mx. Mol. Cell. Biol. 9:3117-21
92. Caipang CM, Hirono I, Aoki T. 2003. In vitro inhibition of fish rhabdoviruses by Japanese flounder, Paralichthys olivaceus Mx. Virology 317:373-82
93. Larsen R, Rokenes TP, Robertsen B. 2004. Inhibition of infectious pancreatic necrosis virus replication by Atlantic salmon Mx1 protein. J. Virol. 78:7938-44
94. Robertsen B. 2006. The interferon system of teleost fish. Fish Shellfish Immunol. 20:172-91
95. Lee SH, Vidal SM. 2002. Functional diversity of Mx proteins: variations on a theme of host resistance to infection. Genome Res. 12:527-30
96. Bazzigher L, Schwarz A, Staeheli P. 1993. No enhanced influenza virus resistance of murine and avian cells expressing cloned duck Mx protein. Virology 195:100-12
97. Bernasconi D, SchultzU, Staeheli P. 1995. The interferon-induced Mx protein of chickens lacks antiviral activity. J. Interferon Cytokine Res. 15:47-53
98. Li XY, Qu LJ, Hou ZC, Yao JF, Xu GY, Yang N. 2007. Genomic structure and diversity of the chicken Mx gene. Poult. Sci. 86:786-89
99. HallerO, Staeheli P,Kochs G. 2009. Protective role of interferon-inducedMxGTPases against influenza viruses. Rev. Sci. Tech. 28:219-31
100. Kolb E, Laine E, Strehler D, Staeheli P. 1992. Resistance to influenza virus infection of Mx transgenic mice expressing Mx protein under the control of two constitutive promoters. J. Virol. 66:1709-16
101. Muller M, Brenig B, Winnacker EL, Brem G. 1992. Transgenic pigs carrying cDNA copies encoding the murine Mx1 protein which confers resistance to influenza virus infection. Gene 121:263-70
102. Arnheiter H, Skuntz S, Noteborn M, Chang S, Meier E. 1990. Transgenic mice with intracellular immunity to influenza virus. Cell 62:51-61
103. Arnheiter H, Frese M, Kambadur R, Meier E, Haller O. 1996. Mx transgenic mice-animal models of health. Curr. Top. Microbiol. Immunol. 206:119-47
104. Aebi M, Fah J, Hurt N, Samuel CE, Thomis D, et al. 1989. cDNA structures and regulation of two interferon-induced human Mx proteins. Mol. Cell. Biol. 9:5062-72
105. Pavlovic J, Zurcher T, Haller O, Staeheli P. 1990. Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein. J. Virol. 64:3370-75
106. Hefti HP, Frese M, Landis H, Di Paolo C, Aguzzi A, et al. 1999. Human MxA protein protects mice lacking a functional alpha/beta interferon system against La Crosse virus and other lethal viral infections. J. Virol. 73:6984-91
107. Miura TA, Carlson JO, Beaty BJ, Bowen RA, Olson KE. 2001. Expression of human MxA protein in mosquito cells interferes with LaCrosse virus replication. J. Virol. 75:3001-3
108. Turan K,Mibayashi M, Sugiyama K, Saito S,Numajiri A,Nagata K. 2004. Nuclear MxA proteins form a complex with influenza virus NP and inhibit the transcription of the engineered influenza virus genome. Nucleic Acids Res. 32:643-52
109. Zimmermann P,Manz B,HallerO, SchwemmleM, Kochs G. 2011. The viral nucleoprotein determines Mx sensitivity of influenza A viruses. J. Virol. 85:8133-40
110. Manz B, Dornfeld D, Gotz V, Zell R, Zimmermann P, et al. 2013. Pandemic influenza A viruses escape from restriction by human MxA through adaptive mutations in the nucleoprotein. PLOS Pathog. 9:e1003279
111. Melen K, Keskinen P, Ronni T, Sareneva T, Lounatmaa K, Julkunen I. 1996. Human MxB protein, an interferon-α-inducible GTPase, contains a nuclear targeting signal and is localized in the heterochromatin region beneath the nuclear envelope. J. Biol. Chem. 271:23478-86
112. King MC, Raposo G, Lemmon MA. 2004. Inhibition of nuclear import and cell-cycle progression by mutated forms of the dynamin-like GTPase MxB. PNAS 101:8957-62
113. Goujon C, Moncorge O, Bauby H, DoyleT,Ward CC, et al. 2013. HumanMX2 is an interferon-induced post-entry inhibitor of HIV-1 infection. Nature 502:559-62
114. KaneM, Yadav SS, Bitzegeio J, Kutluay SB, Zang T, et al. 2013. MX2 is an interferon-induced inhibitor of HIV-1 infection. Nature 502:563-66
115. Liu Z, Pan Q, Ding S, Qian J, Xu F, et al. 2013. The interferon-inducible MxB protein inhibits HIV-1 infection. Cell Host Microbe 14:398-410
116. Haller O. 2013. Dynamins are forever: MxB inhibits HIV-1. Cell Host Microbe 14:371-73
117. Gao S, von derMalsburgA, Paeschke S, Behlke J,HallerO, et al. 2010. Structural basis of oligomerization in the stalk region of dynamin-like MxA. Nature 465:502-6
118. Gao S, von der Malsburg A, Dick A, Faelber K, Schroder GF, et al. 2011. Structure of myxovirus resistance protein A reveals intra-and intermolecular domain interactions required for the antiviral function. Immunity 35:514-25
119. HallerO,Gao S, von der MalsburgA,DaumkeO,Kochs G. 2010. Dynamin-likeMxA GTPase: structural insights into oligomerization and implications for antiviral activity. J. Biol. Chem. 285:28419-24
120. Daumke O, Gao S, von derMalsburg A, Haller O, Kochs G. 2010. Structure of the MxA stalk elucidates the assembly of ring-like units of an antiviral module. Small GTPases 1:62-64
121. Faelber K, Posor Y, Gao S, Held M, Roske Y, et al. 2011. Crystal structure of nucleotide-free dynamin. Nature 477:556-60
122. Ford MG, Jenni S, Nunnari J. 2011. The crystal structure of dynamin. Nature 477:561-66
123. Antonny B, Burd C, De Camilli P, Chen E, Daumke O, et al. 2016. Membrane fission by dynamin: what we know and what we need to know. EMBO J. 35:2270-84
124. Mitchell PS, Young JM, Emerman M, Malik HS. 2015. Evolutionary analyses suggest a function ofMxB immunity proteins beyond lentivirus restriction. PLOS Pathog. 11:e1005304
125. Verhelst J, Hulpiau P, Saelens X. 2013. Mx proteins: antiviral gatekeepers that restrain the uninvited. Microbiol. Mol. Biol. Rev. 77:551-66
126. Ciancanelli MJ, Abel L, Zhang SY, Casanova JL. 2016. Host genetics of severe influenza: from mouse Mx1 to human IRF7. Curr. Opin. Immunol. 38:109-20
127. Horby P, Nguyen NY, Dunstan SJ, Baillie JK. 2012. The role of host genetics in susceptibility to influenza: a systematic review. PLOS ONE 7:e33180
128. Pavlovic J, Arzet HA, Hefti HP, Frese M, Rost D, et al. 1995. Enhanced virus resistance of transgenic mice expressing the human MxA protein. J. Virol. 69:4506-10
129. Deeg CM, Hassan E, Mutz P, Rheinemann L, Gotz V, et al. 2017. In vivo evasion of MxA by avian influenza viruses requires human signature in the viral nucleoprotein. J. Exp. Med. 214:1239-48
130. Staeheli P, Danielson P, Haller O, Sutcliffe JG. 1986. Transcriptional activation of the mouse Mx gene by type I interferon. Mol. Cell. Biol. 6:4770-74
131. Hug H, Costas M, Staeheli P, Aebi M, Weissmann C. 1988. Organization of the murine Mx gene and characterization of its interferon-and virus-inducible promoter. Mol. Cell. Biol. 8:3065-79
132. Kuhn R, Schwenk F, Aguet M, Rajewsky K. 1995. Inducible gene targeting in mice. Science 269:1427-29
133. Velasco-HernandezT, Sawen P, Bryder D, Cammenga J. 2016. Potential pitfalls of theMx1-Cre system: implications for experimental modeling of normal and malignant hematopoiesis. Stem Cell Rep. 7:11-18
134. von Wussow P, Jakschies D, Block B, Tschechne B, Schedel I, et al. 1990. The interferon-induced Mx-homologous protein in people with symptomatic HIV-1 infection. AIDS 4:119-24
135. Jakschies D, Hochkeppel H, Horisberger M, Deicher H, vonWussow P. 1990. Emergence and decay of the human Mx homolog in cancer patients during and after interferon-αtherapy. J. Biol. ResponseModif. 9:305-12
136. Fah J, Pavlovic J, Burg G. 1995. Expression of MxA protein in inflammatory dermatoses. J. Histochem. Cytochem. 43:47-52
137. Roers A,HochkeppelHK, HorisbergerMA, Hovanessian A, Haller O. 1994. MxA gene expression after live virus vaccination: a sensitive marker for endogenous type I interferon. J. Infect. Dis. 169:807-13
138. Jorns C, Holzinger D, Thimme R, Spangenberg HC, Weidmann M, et al. 2006. Rapid and simple detection of IFN-neutralizing antibodies in chronic hepatitis C non-responsive to IFN-α. J. Med. Virol. 78:74-82
139. CrameriM,Bauer M, CaduffN,Walker R, Steiner F, et al. 2018.MxBis an interferon-induced restriction factor of human herpesviruses. Nat. Commun. 9:1980
140. Schilling M, Bulli L, Weigang S, Graf L, Naumann S, et al. 2018. MxB protein is a pan-herpesvirus restriction factor. J. Virol. In press